Skip to content

Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes

Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02875665
Enrollment
13
Registered
2016-08-23
Start date
2016-04-30
Completion date
2017-09-30
Last updated
2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fecal Incontinence

Brief summary

This research aims to investigate the feasibility for the treatment of OnPulse(TM) for the treatment of faecal incontinence (FI) (including mixed faecal and urinary incontinence) in older people living at home or in a Care Home. It will determine patient acceptability, tolerability and usability of the T-2 gekoTM device for FI by assessing: 1. device user factors: acceptability of use, ease of device placement, ease of device interface control and understanding of device instructions; 2. tolerability of device: skin tolerability.

Interventions

DEVICEgeko(TM) device

The geko(TM) device will be used to electrically stimulate the posterior tibial nerve

Sponsors

Firstkind Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

The intervention is the using geko device

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or Female 2. Aged 60 and over? 3. Reporting faecal incontinence of any severity 4. Living in own home or a Care Home 5. Able to understand the Patient Information Sheet and willing to sign the written Informed Consent Form. 6. Able and willing to follow the protocol requirements.

Exclusion criteria

1. Patients or Carers unable to speak, read or understand English 2. Patients or Carers unable to give informed consent because of lack of capacity 3. Patients with leg conditions (such as a venous ulcer) that would preclude placement of the gekoTM device. 4. Have implantable electronic devices 5. Has sore, infected or inflamed areas, broken skin or skin eruptions for example phlebitis, thrombophlebitis, venous leg ulcers, varicose veins etc. in the region where the device would be fitted. 6. Any cancerous lesions in the lower limb 7. Is pregnant

Design outcomes

Primary

MeasureTime frameDescription
Reviewing the views of older people with faecal incontinence and their formal and informal carers on using the CE marked gekoTM tibial nerve stimulator device in their place of usual residence with regards to ease of use of the device and tolerability.1 weekUsing semi-structured interview style with a topic guide pre and post treatment with gekoTM device- researching the views of the patients using their own words to describe what they felt using geko device. Interviews will be digitally recorded and professionally transcribed through verbatim. Data will be anonymised and analysed using a pragmatic thematic analysis (1). NVivo will be used to support the analysis.

Secondary

MeasureTime frameDescription
Studying the feasibility of older people or their carers applying the device1 weekInterviews performed post treatment will measure this aspect of the study
Skin reactions to using the device on the leg of older people measured by clinical examination1 weekdigital photos will be takes pre and post treatment with geko TM device. The digital photos will be viewed in random order from each participant by a second researcher blinded as to before or after status, and rated for signs of skin reaction using the categories: none, mild, moderate and severe.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026